Primary focal segmental glomerulosclerosis: Clinical course, predictors of renal outcome and treatment

Internal Medicine

Volumn 39, Issue 8, 2000, Pages 606-611

  Shiiki, Hideo ^a   Dohi, Kazuhiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Predictors; Prognosis; Treatment

Indexed keywords

ALKYLATING AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BENAZEPRIL; CHLORAMBUCIL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; DILAZEP; DIPYRIDAMOLE; MIZORIBINE; PREDNISOLONE;

CREATININE BLOOD LEVEL; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; JAPAN; KIDNEY FAILURE; NEPHROTIC SYNDROME; PLASMAPHERESIS; PROGNOSIS; REMISSION; REVIEW; SURVIVAL RATE; TREATMENT PLANNING;

EID: 0033852274     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.606     Document Type: Review

References (59)

1. Velosa JA, Donadio JV Jr, Holley KE. Focal sclerosing glomerulonephropathy: a clinicopathologic study. Mayo Clin Proc 50: 121-133, 1975.
2. Goldszer RC, Sweet J, Cotran RS. Focal segmental glomerulosclerosis. Annu Rev Med 35: 429-449, 1984.
3. Rich AR. A hitherto undescribed vulnerability of the juxta-medullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100: 173-186, 1957.
4. Habib R. Focal glomerular sclerosis. Kidney Int 4: 355-361, 1973.
5. Korbet SM, Schwartz MM, Lewis EJ. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23: 773-783, 1994.
6. Ponticelli C, Villa M, Banfi G, et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 34: 618-625, 1999.
7. Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R. Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. Am J Kidney Dis 25: 845-852, 1995.
8. Cameron JS, Turner DR, Ogg CS, Chantier C, Williams DG. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10: 213-218, 1978.
9. Velosa JA, Holley KE, Torres VE, Offord KP. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58: 568-577, 1983.
10. Korbet SM, Schwartz MM, Lewis EJ. The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine (Baltimore) 65: 304-311, 1986.
11. Arbus GS, Poucell S, Bacheyie GS, Baumal R. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. J Pediatr 101: 40-45, 1982.
12. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36: 53-59, 1991.
13. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32: 72-79, 1998.
14. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82: 938-944, 1987.
15. Dohi K. Summary of refractory nephrotic syndrome. Annual report of "Progressive Renal Disease" from "Specially selected diseases by the Ministry of Health and Welfare Reseach Project" (in Japanese). 1999: 55-65.
16. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H. Long-term prognosis of focal sclerosing glomerulonephritis: an analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33: 115-122, 1990.
17. Brown CB, Cameron JS, Turner DR, et al. Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS"). Clin Nephrol 10: 51-61, 1978.
18. Ito H, Yoshikawa N, Aozai F, et al. Twenty-seven children with focal segmental glomerulosclerosis: correlation between the segmental location of the glomerular lesions and prognosis. Clin Nephrol 22: 9-14, 1984.
19. Shiiki H, Nishino T, Uyama H, et al. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS). Clin Nephrol 46: 362-368, 1996.
20. Baldwin DS, Neugarten J. Treatment of hypertension in renal disease. Am J Kidney Dis 5: A57-70, 1985.
21. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5: 393-397, 1991.
22. Kohaut EC, Edwards GA, Hill LL, Rosenberg HS, Hartley MW. Focal glomerulosclerosis. Extent of involvement related to steroid resistance. Am J Clin Pathol 75: 181-185, 1981.
23. Waldherr R, Gubler MC, Levy M, Broyer M, Habib R. The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol 10: 171-179, 1978.
24. Miyata J, Takebayashi S, Taguchi T, Harada T. Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis. Nephron 44: 115-120, 1986.
25. A report of the Southwest Pediatric Nephrology Study Group: Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 27: 442-449, 1985.
26. Howie AJ, Brewer DB. The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality. J Pathol 142: 205-220, 1984.
27. Poucell S, Baumal R, Farine M, Arbus GS. Location of glomerular lesions in focal segmental glomerulosclerosis. Arch Pathol Lab Med 109: 482-483, 1985 (letter).
28. Morita M, White RH, Coad NA, Raafat F. The clinical significance of the glomerular location of segmental lesions in focal segmental glomerulosclerosis. Clin Nephrol 33: 211-219, 1990.
29. Howie AJ, Brewer DB. Further studies on the glomerular tip lesion: early and late stages and life table analysis. J Pathol 147: 245-255, 1985.
30. Schwartz MM, Lewis EJ. Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int 28: 968-974, 1985.
31. ) Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinical and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424, 1994.
32. Schwartz MM, Evans J, Bain R, Korbet SM. Focal segmental glomerulosclerosis: prognostic implications of the cellular lesion. J Am Soc Nephrol 10: 1900-1907, 1999.
33. Wehrmann M, Bohle A, Bogenschütz O, et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 31: 67-76, 1989.
34. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membrano-proliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases. Nephron 55: 242-250, 1990.
35. Katafuchi R, Takebayashi S, Taguchi T, Harada T. Structural-functional correlations in serial biopsies from patients with glomerulonephritis. Clin Nephrol 28: 169-173, 1987.
36. Fogo A, Hawkins EP, Berry PL, et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38: 115-123, 1990.
37. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 46: 1223-1241, 1994.
38. Nishimoto K, Shiiki H, Nishino T, Uyama H, Iwano M, Dohi K. Reversible glomerular hypertrophy in adult patients with primary focal segmental glomerulosclerosis. J Am Soc Nephrol 8: 1668-1678, 1997.
39. Nyberg E, Bohman SO, Berg U. Glomerular volume and renal function in children with different types of the nephrotic syndrome. Pediatr Nephrol 8: 285-289, 1994.
40. Ponticelli C, Passerini P. Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 46: 595-604, 1994.
41. Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9: 1333-1340, 1998.
42. Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int Suppl 70: S26-S32, 1999.
43. Ponticelli C, Rizzoni G, Edefonti A, et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43: 1377-1384, 1993.
44. Ponticelli C, Edefonti A, Ghio L, el al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 8: 1326-1332, 1993.
45. Lieberman KV, Tejani A, New York-New Jersey Pediatric Nephrology Study Group. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7: 56-63, 1996.
46. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 33: 590-600, 1988.
47. Meyrier A, Noel L-H, Auriche P, Callard P, and Collaborative Group of the Societe de Nephrologie. Long-term renal tolerance of cyclosporine A treatment in adult idiopathic nephrotic syndrome. Kidney Int 45: 1446-1456, 1994.
48. Cattran DC, Appel GB, Hebert LA et al. and the North America nephrotic syndrome study group. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 56: 2223-2226, 1999.
49. Bedogna V, Valvo E, Casagrande P, et al. Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 38: 101-107, 1990.
50. Huissoon A, Meehan S, Keogh JA. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy. Ir J Med Sci 160: 319-321, 1991.
51. Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240-248, 1992.
52. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334: 939-945, 1996.
53. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33: 917-924, 1988.
54. Muso E, Mune M, Fujii Y, et al. and the Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kidney Int Suppl 71: S122-S125, 1999.
55. Dental J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 7-14, 1994.
56. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmentai glomerulosclerosis. N Engl J Med 334: 878-883, 1996.
57. Artero M, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23: 574-581, 1994.
58. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 20: 765-771, 1981.
59. Nishimoto K, Nakatani K, Uyama H, et al. Morphological characteristics of non-nephrotic FSGS: a morphometric study. Jpn J Nephrol 41: 325, 1999 (abstract, in Japanese).